Le Lézard
Classified in: Health

Stratosphere Networks Sponsors Anixter Center's Pure Imagination Event


Tech advisory firm contributes to annual fundraiser to support disability, mental health services

CHICAGO, May 9, 2024 /PRNewswire-PRWeb/ -- Stratosphere Networks has announced it will sponsor the Anixter Center's annual fundraiser. The Pure Imagination event will take place on Thursday, May 23, from 6 to 9 p.m. at Venue West at 221 N. Paulina St. in Chicago.

The Anixter Center provides vital services to the Chicago community, and our team fully supports the organization's life-changing efforts.

The event will include appetizers, cocktails, and networking. Proceeds will support the Anixter Center's work serving individuals in the Chicago area. Since 1919, the Anixter Center has helped hundreds of thousands by providing services for people living with disabilities and mental health needs. The Center also serves those who are Deaf, DeafBlind, and Hard of Hearing.

"We're very pleased to sponsor the Pure Imagination event," said Kevin Rubin, president and CIO of Stratosphere Networks. "The Anixter Center provides vital services to the Chicago community, and our team fully supports the organization's life-changing efforts."    

Stratosphere also sponsored the Anixter Center's annual fundraiser in 2023.

To learn more about the Pure Imagination event, donate, or purchase tickets ($225 per person), please visit the Anixter Center's website.

About Stratosphere Networks

Stratosphere Networks helps businesses bypass the traditional sales process and quickly identify leading Unified Communications as a Service (UCaaS), Contact Center as a Service (CCaaS), customer experience (CX), digital transformation, business process outsourcing (BPO), Infrastructure as a Service (IaaS), data center, managed IT and cybersecurity solutions. Leveraging advanced tools and in-depth knowledge of the technology landscape, our team identifies products and services that position our clients for lasting success. Our team also offers white-glove implementation and project management services, saving our clients time and ensuring the best possible results for their new solutions. With a proven process, we drive end-user adoption with training services, maximize feature functionality with supplier negotiations, and assure lasting high-level performance with ongoing management services. Visit http://www.stratospherenetworks.com for more information.

For more information contact:

Lori Leonardo
847-440-8608
[email protected]

Media Contact

Lori Leonardo, Stratosphere Networks, 847-440-8608, [email protected], https://www.stratospherenetworks.com/

SOURCE Stratosphere Networks


These press releases may also interest you

at 03:15
Cresilon Announces International Distribution Agreement for VETIGEL with Covetrus
Cresilon Inc. ("Cresilon"), a Brooklyn-based biotechnology company focused on haemostatic medical device technologies, today announced it has entered into a distribution agreement for its revolutionary haemostatic gel, VETIGEL®, to be sold directly...

at 02:30
New Research by Tea Advisory Panel Reveals That Three Quarters Of Brits Never Drink Tea Before A Workout Despite It Counting Towards Fluid Intake Recommendations
Ahead of International Tea Day - 21st May 2024  - and with summer inspiring more of us to get off the sofa to be active, a 2024 real-world research study1 reviewed by the tea science experts at the Tea Advisory Panel ? www.teaadvisorypanel.com -...

at 02:30
TREEFROG PRESENTS DATA FROM THEIR PARKINSON'S DISEASE CELL THERAPY PROGRAM AT THE 29TH WORLD CONGRESS ON PARKINSON'S DISEASE AND RELATED DISORDERS (IAPRD) IN LISBON
TreeFrog Therapeutics will participate for the first time at the IAPRD, to present data from their Parkinson's disease cell therapy program, which has demonstrated excellent results with full motor recovery at 16 weeks in preclinical studies.[1]...

at 02:20
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid Improves Lung Function Over 36 Weeks in Patients with Idiopathic Pulmonary Fibrosis
Vicore Pharma Holding (STO:VICO)Buloxibutid improved lung function-measured by FVC-by over 200 mL from baseline at 36 weeks of treatment.The therapy was safe and well tolerated with no treatment-related serious adverse events.Biomarker analysis...

at 02:07
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Approval
GC Biopharma (006280. KS) and Novel Pharma announced that its jointly developed MPS IIIA 'GC1130A' treatment has received FDA IND approval....

at 02:05
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
PureTech Health plc ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announces the opening of its proposed $100 million tender offer (the "Tender...

More news about Health...


News published on and distributed by: